IPP Bureau
USFDA approves two Opdivo-based regimens
By IPP Bureau - May 29, 2022
Opdivo-based treatments are now approved for five indications in upper gastroesophageal cancers
USFDA approves Novartis Kymriah CAR-T cell therapy
By IPP Bureau - May 29, 2022
68% of patients receiving Kymriah in the ELARA trial experienced a complete response, with an 86% overall response rate, along with a remarkable safety profile
All India Institute of Ayurveda launches #YogaSeAyu campaign for International Day of Yoga 2022
By IPP Bureau - May 29, 2022
The campaign aims to promote an integrated view by combining Ayurveda and Yoga to create harmony not just within the body, but also in our minds
MVA-BN respiratory syncytial virus vaccine could get first-to-market opportunity in China, says GlobalData
By IPP Bureau - May 29, 2022
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
JBCL rebrands as JB
By IPP Bureau - May 29, 2022
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
Torrent Pharma acquires four brands from Dr Reddy’s
By IPP Bureau - May 27, 2022
The integration and transition of the brands are expected to be completed by June 2022.
Next-gen immunotherapy drug shows promise in several advanced-stage cancers
By IPP Bureau - May 27, 2022
Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells
CorePath partners with Cizzle Bio to develop blood test to detect lung cancer
By IPP Bureau - May 27, 2022
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
USFDA approves Omeprazole capsules to prevent heartburn
By IPP Bureau - May 27, 2022
Perrigo expects to launch Omeprazole Minis later this year
Revolutionary wearable ultrasound device gains USFDA approval
By IPP Bureau - May 27, 2022
Manamed, a pioneering Medical Technology development company, has been granted FDA approval on its latest orthopaedic recovery device, ManaSport.
Bempedoic acid market in India will get crowded soon: GlobalData
By IPP Bureau - May 27, 2022
Bempedoic acid helps lower cardiovascular risk in high or very high-risk atherosclerotic cardiovascular disease (ASCVD) patients as an add-on therapy to maximally tolerated statin and/or ezetimibe
Lancet publishes results of Phase 3 programmes of Rinvoq in Ulcerative Colitis
By IPP Bureau - May 27, 2022
Data from the three studies formed the basis of the company's application for approval by regulatory agencies
New data demonstrate clinical benefit of Roche’s glofitamab
By IPP Bureau - May 27, 2022
Glofitamab has the potential to offer a readily available, fixed-duration CD20xCD3 bispecific antibody treatment approach for people with aggressive lymphoma
A.Menarini expands its dermatology portfolio with the launch of Solar D
By IPP Bureau - May 27, 2022
The groundbreaking SPF technology is specifically designed and formulated to prevent sunburn or sun damage while allowing the passage of sufficient UVB light that our bodies use to naturally produce vitamin D
DFE Pharma opens its new Center of Excellence in Hyderabad, India
By IPP Bureau - May 27, 2022
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
